Ismail H.
Patient Review
United Kingdom
Applied Treatment
YAG Laser and Glaucoma Surgery in Turkey
Operation Date
25 June 2024
Date of Return Home
29 June 2024
Examinations/Analysis
All pre-operative eye tests
Satisfaction Rate
Laser Eye Reviews
Ismail Hafejee's Successful YAG Laser and Glaucoma Surgery Journey in Turkey
Background:
Ismail H., who underwent cataract surgery in 2007, was experiencing cloudy and blurred vision. He had been suffering from glaucoma for 20 years and was using eye drops, which led to the revocation of his driving license. To improve his vision, eliminate the need for eye drops, and regain his driving license, he contacted Medicalart Turkey.
Treatment Plan:
Upon arrival in Turkey, Ismail underwent a YAG laser procedure to clear the cloudy and hazy vision that developed long after his cataract surgery. The goal of the glaucoma surgery was to lower his intraocular pressure and eliminate the need for eye drops.
Treatment Process:
YAG Laser: Performed on the second day of Ismail's arrival. The procedure took just 10 minutes.
Glaucoma Surgery: Conducted on the third day.
Post-Treatment and Follow-Up:
After the treatment, Ismail was very happy with the results. One month later, during his follow-up in the UK, his intraocular pressure had dropped from 18 to 8. He applied to regain his driving license and will update us on the outcome.
Ismail was highly satisfied with our clinic, team, and doctor. He is delighted with his improved vision and has expressed his intention to recommend us to others.
Recommendations:
We advised Ismail to use his eye drops for one month and then have a follow-up examination with his eye doctor after another month. However, due to his need to see the doctor for his driving license, he had a check-up at the one-month mark, showing significant improvement, and he was very pleased with his progress.
Pre and Post-Treatment Eye Examination Reports:
Below, you can see Ismail's eye examination reports. The first report shows his condition before coming to Turkey, and the second report reflects the results after his treatment and follow-up in the UK.